Literature DB >> 15981751

Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease.

Bernward Zeller1, Jukka Rajantie, Iris Hedlund-Treutiger, Ulf Tedgård, Finn Wesenberg, Olafur G Jonsson, Jan Inge Henter.   

Abstract

AIM: To describe the epidemiology of idiopathic thrombocytopenic purpura (ITP) in the Nordic countries, to define clinical subgroups and to investigate factors predicting chronic disease.
METHODS: A prospective registration was done from 1998 to 2000, including all children with newly diagnosed ITP aged 0-14 y and at least one platelet count <30 x 10(9)/l.
RESULTS: 506 children were registered and 423 followed for 6 mo. The incidence was 4.8/10(5) per year. Most children were aged 0-7 y (78%), with a predominance of boys, while patients aged 8-14 y had equal representation of the two sexes. There were seasonal variations determined by variations in postinfectious cases with sudden onset. The platelet count was <10 x 10(9)/l in 58%, but bleeding manifestations were mild or moderate in 97%. The insidious form (symptoms for more than 2 wk) was more frequent in older children and girls, showed little seasonal variation, had milder manifestations and ran a chronic course in more than half the cases. Intracranial haemorrhages did not occur in the first 6 mo after diagnosis. Chronic ITP developed in 25%. The strongest predictor of chronic disease was insidious onset of symptoms (OR 5.97).
CONCLUSION: In the Nordic countries, ITP mainly affects children aged 0-7 y, with a winter bulk of postinfectious cases superimposed on a steady occurrence of non-infectious cases. Clinically, it may be useful to distinguish between children with sudden versus insidious onset of symptoms rather than between different age groups.

Entities:  

Mesh:

Year:  2005        PMID: 15981751     DOI: 10.1111/j.1651-2227.2005.tb01887.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  27 in total

1.  Seasonal variation of immune thrombocytopenic purpura related hospitalizations among adults in the USA: analysis of the nationwide inpatient sample database.

Authors:  Smith Giri; Ranjan Pathak; Madan R Aryal; Paras Karmacharya; Vijaya R Bhatt; Mike G Martin
Journal:  Ther Adv Hematol       Date:  2015-08

2.  Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity?

Authors:  Iris Treutiger; Jukka Rajantie; Bernward Zeller; Jan-Inge Henter; Göran Elinder; Steen Rosthøj
Journal:  Arch Dis Child       Date:  2007-04-25       Impact factor: 3.791

3.  Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome.

Authors:  Lamiae Grimaldi-Bensouda; Clémentine Nordon; Marc Michel; Jean-François Viallard; Daniel Adoue; Nadine Magy-Bertrand; Jean-Marc Durand; Philippe Quittet; Olivier Fain; Bernard Bonnotte; Anne-Sophie Morin; Nathalie Morel; Nathalie Costedoat-Chalumeau; Brigitte Pan-Petesch; Mehdi Khellaf; Antoinette Perlat; Karim Sacre; François Lefrere; Lucien Abenhaim; Bertrand Godeau
Journal:  Haematologica       Date:  2016-05-26       Impact factor: 9.941

Review 4.  Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review.

Authors:  Yoshiyuki Kurata; Kingo Fujimura; Masataka Kuwana; Yoshiaki Tomiyama; Mitsuru Murata
Journal:  Int J Hematol       Date:  2011-02-24       Impact factor: 2.490

5.  Immune Thrombocytopenia and Obesity: Predictive Relationship.

Authors:  Ehab Hanafy; Mohammed Al Pakra
Journal:  Ochsner J       Date:  2017

Review 6.  Clinical practice: immune thrombocytopenia in paediatrics.

Authors:  Veerle Labarque; Chris Van Geet
Journal:  Eur J Pediatr       Date:  2014-01-05       Impact factor: 3.183

Review 7.  Immune thrombocytopenia.

Authors:  Gaurav Kistangari; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2013-06       Impact factor: 3.722

8.  Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.

Authors:  Steven Black; Juhani Eskola; Claire-Anne Siegrist; Neal Halsey; Noni MacDonald; Barbara Law; Elizabeth Miller; Nick Andrews; Julia Stowe; Daniel Salmon; Kirsten Vannice; Hector S Izurieta; Aysha Akhtar; Mike Gold; Gabriel Oselka; Patrick Zuber; Dina Pfeifer; Claudia Vellozzi
Journal:  Lancet       Date:  2009-10-31       Impact factor: 79.321

9.  Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases.

Authors:  Bethan Psaila; Aleksandra Petrovic; Lemke K Page; Jill Menell; Matthew Schonholz; James B Bussel
Journal:  Blood       Date:  2009-09-18       Impact factor: 22.113

10.  Seasonal Association of Immune Thrombocytopenia in Adults.

Authors:  Anıl Tombak; Burcu Boztepe; Naci Tiftik; Melda Cömert; Ozan Salim; Kaniye Aydın; Emel Gürkan; Orhan Kemal Yücel; Güray Saydam; Mehmet Ali Sungur
Journal:  Balkan Med J       Date:  2015-10-01       Impact factor: 2.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.